Morbidly obese patients remain an unsolved clinical problem,” explained co-author Gwo-Chin Lee, M.D., a hip and knee replacement surgeon at HSS. “Traditional weight loss measures have had mixed ...

A new Canadian guideline urges lifestyle interventions for obese children but also says today's new drugs might help kids ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.

In one study, once-daily danuglipron resulted in one patient who experienced drug-related elevated liver enzymes.

Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its ...

So we turned to an expert on the subject to address the top five concerns women have about starting GLP-1 meds like Ozempic. Here, how to outsmart common side effects and hurdles.  Meet our Ozempic ...

Preoperative GLP-1RA use was not significantly associated with an increased risk for postoperative aspiration pneumonia or acute respiratory failure.

In the long term, bariatric surgery is more cost-effective than new anti-obesity medications, research finds, triggering a ...

GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.